[PDF][PDF] Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms
Individuals with coronavirus disease 2019 (COVID-19) frequently develop neurological
symptoms, but the biological underpinnings of these phenomena are unknown. Through single-…
symptoms, but the biological underpinnings of these phenomena are unknown. Through single-…
[HTML][HTML] Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
…, MT Laurie, CR Zamecnik, R Dandekar, BD Alvarenga… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Vaccine-elicited adaptive immunity is a prerequisite for control of SARS-CoV-2
infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially target …
infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially target …
[PDF][PDF] ReScan, a multiplex diagnostic pipeline, pans human sera for SARS-CoV-2 antigens
…, RP Loudermilk, GM Sowa, KC Zorn, BD Alvarenga… - Cell Reports …, 2020 - cell.com
Comprehensive understanding of the serological response to SARS-CoV-2 infection is important
for both pathophysiologic insight and diagnostic development. Here, we generate a pan…
for both pathophysiologic insight and diagnostic development. Here, we generate a pan…
Anti–SARS-CoV-2 and autoantibody profiles in the cerebrospinal fluid of 3 teenaged patients with COVID-19 and subacute neuropsychiatric symptoms
…, R Dandekar, RL Loudermilk, BD Alvarenga… - JAMA …, 2021 - jamanetwork.com
Importance Neuropsychiatric manifestations of COVID-19 have been reported in the
pediatric population. Objective To determine whether anti–SARS-CoV-2 and autoreactive …
pediatric population. Objective To determine whether anti–SARS-CoV-2 and autoreactive …
[HTML][HTML] Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
…, JV Rajan, CR Zamecnik, R Dandekar, BD Alvarenga… - medRxiv, 2021 - ncbi.nlm.nih.gov
Vaccine-elicited adaptive immunity is an essential prerequisite for effective prevention and
control of coronavirus 19 (COVID-19). Treatment of multiple sclerosis (MS) involves a diverse …
control of coronavirus 19 (COVID-19). Treatment of multiple sclerosis (MS) involves a diverse …
Detection of High‐Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins
…, S Muñiz‐Castrillo, BD Alvarenga… - Annals of …, 2023 - Wiley Online Library
Objective Co‐occurring anti‐tripartite motif‐containing protein 9 and 67 autoantibodies (TRIM9/67‐IgG)
have been reported in only a very few cases of paraneoplastic cerebellar …
have been reported in only a very few cases of paraneoplastic cerebellar …
[HTML][HTML] Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement
One third of COVID-19 patients develop significant neurological symptoms, yet SARS-CoV-2
is rarely detected in central nervous system (CNS) tissue, suggesting a potential role for …
is rarely detected in central nervous system (CNS) tissue, suggesting a potential role for …
[HTML][HTML] Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report
…, A Harroud, RD Schubert, BD Alvarenga… - Frontiers in …, 2023 - frontiersin.org
Neuroinvasive infection is the most common cause of meningoencephalitis in people living
with human immunodeficiency virus (HIV), but autoimmune etiologies have been reported. …
with human immunodeficiency virus (HIV), but autoimmune etiologies have been reported. …
βIV-spectrin autoantibodies in 2 individuals with neuropathy of possible paraneoplastic origin: a case series
CM Bartley, TT Ngo, BD Alvarenga… - Neurology …, 2022 - AAN Enterprises
Objective To identify the autoantigen in 2 individuals with possible seronegative paraneoplastic
neuropathy. Methods Serum and CSF were screened by tissue-based assay and …
neuropathy. Methods Serum and CSF were screened by tissue-based assay and …
Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin
…, R Dandekar, BD Alvarenga… - Biological …, 2023 - biologicalpsychiatryjournal.com
Patients with COVID-19 are at increased risk for developing new or recurrent psychosis (1, 2).
Viral infections—including SARS-CoV-2 (3–5)—can cause psychosis in the context of …
Viral infections—including SARS-CoV-2 (3–5)—can cause psychosis in the context of …